6:12 am Valeant Pharma beats by $0.09, reports revs in-line; reaffirms FY14 EPS guidance, guides FY14 revs in-line – HedgeChatter

6:12 am Valeant Pharma beats by $0.09, reports revs in-line; reaffirms FY14 EPS guidance, guides FY14 revs in-line

27 Feb

6:12 am Valeant Pharma beats by $0.09, reports revs in-line; reaffirms FY14 EPS guidance, guides FY14 revs in-line

Bystocknews stock, VRX Comments Off

View todays social media effects on VRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Valeant is hiring next, click here to view

Author